Search
for

    Sort by

    Research 91–120 of 1000+

    1. COLLAB: A Global Survey of Clinical and Laboratory Assessment in Alopecia Areata by Hair Specialists JEADV Clinical Practice · 2025
    2. Advances in the mechanism and new therapies of alopecia areata International journal of rheumatic diseases · 2023
    3. Role of topical tofacitinib in autoimmune skin disorders: An expert opinion IP Indian Journal of Clinical and Experimental Dermatology · 2024 · 1 citations
    4. Chemotherapy-Induced Alopecia Beyond Cytotoxicity: Hair Follicle Immune Privilege Collapse and JAK-STAT Signaling International Journal of Molecular Sciences · 2026
    5. Multiomic Characterization of Treatment Response to JAK Inhibition in Patients with APECED Journal of Human Immunity · 2026
    6. Alopecia Areata Treatment: Past, Present, and Future Dermatological Reviews · 2024
    7. The JAK/STAT signaling pathway: from bench to clinic Signal Transduction and Targeted Therapy · 2021 · 489 citations
    8. Management of folliculitis decalvans: The EADV task force on hair diseases position statement Journal of the European Academy of Dermatology and Venereology · 2025 · 5 citations
    9. Evaluation of Effectiveness of Bio-Micro Injection in Treating Alopecia Universalis: A Non-Randomized Interventional Study Galen Medical Journal · 2025
    10. Scarring hair follicle destruction is driven by the collapse of EGFR-protected JAK-STAT1-sensitive stem cell immune privilege bioRxiv (Cold Spring Harbor Laboratory) · 2023
    11. 865 Conditional ablation of JAK-STAT5 signaling induces anagen hair growth Journal of Investigative Dermatology · 2017
    12. The emerging role of Janus kinase inhibitors in the treatment of autoimmune and inflammatory diseases 2020 · 70 citations
    13. Minoxidil Sulfate Regulates JAK / STAT Signalling and Mitochondrial Function in Alopecia Areata Experimental Dermatology · 2026
    14. USE OF TOFACITINIB IN DIFFICULT TO TREAT CLINICALLY AMYOPATHIC DERMATOMYOSITIS XXXIX Congresso Brasileiro de Reumatologia · 2022
    15. Ruxolitinib reverses alopecia areata via a triple mechanism: JAK-STAT inhibition, localized oxidative stress attenuation and selective apoptosis modulation Journal of Translational Autoimmunity · 2026
    16. Ruxolitinib: A novel molecule in the management of dermatological disorders Indian Journal of Skin Allergy · 2026
    17. USE OF UPADACITINIB IN 2 CASES OF REFRACTORY SYSTEMIC LUPUS ERYTHEMATOSUS The Journal of Rheumatology · 2025 · 1 citations
    18. Selective Janus kinase 1 inhibition resolves inflammation and restores hair growth offering a viable treatment option for alopecia areata Skin health and disease · 2023 · 4 citations
    19. Experience with oral tofacitinib in 8 adolescent patients with alopecia universalis Journal of the American Academy of Dermatology · 2017 · 49 citations
    20. Topical tofacitinib for patients with lichen planopilaris and/or frontal fibrosing alopecia Journal of the American Academy of Dermatology · 2024 · 3 citations
    21. Clinical Features and Treatment Options of Vogt-Koyanagi-Harada Disease IntechOpen eBooks · 2025 · 2 citations
    22. Treatment of pediatric alopecia areata: A systematic review Journal of the American Academy of Dermatology · 2021 · 48 citations
    23. Assessing Alopecia Areata Management in Poland: Challenges in Medical Practices and Patient Care Journal of Clinical Medicine · 2026
    24. Comparative analysis of therapeutic outcomes in pediatric versus adult ophiasis-pattern alopecia areata: A review of treatment modalities and disease course Saudi Journal of Internal Medicine · 2026
    25. Novel investigational drugs for alopecia areata and future perspectives Expert opinion on investigational drugs · 2024
    26. Alopecia areata: a review on diagnosis, immunological etiopathogenesis and treatment options Clinical and Experimental Medicine · 2021 · 56 citations
    27. Insights into the Diagnostics and Therapeutics of Alopecia Areata—An Indian Context Indian Dermatology Online Journal · 2025
    28. Markers of Venous Thromboembolism Risk in Patients with Alopecia Areata: Is There Anything to Worry about? Dermatology and therapy · 2023
    29. The Safety and Efficacy of Tofacitinib in 24 Cases of Pediatric Rheumatic Diseases: Single Centre Experience Frontiers in Pediatrics · 2022 · 35 citations
    30. Exploring the efficacy of baricitinib in treating alopecia areata after failed Janus kinase inhibitor therapy JAAD Case Reports · 2023 · 7 citations